Choe Youngshik, Lee Byung Ju, Kim Kyungjin
School of Biological Sciences, Seoul National University, Seoul, Korea.
J Neurochem. 2002 Dec;83(6):1412-22. doi: 10.1046/j.1471-4159.2002.01246.x.
In the present study, we investigated the selective role of protein kinase C (PKC) isoforms on neurite outgrowth of the GT1 hypothalamic neurons using several PKC isoform-selective inhibitors and transfection-based expression of enhanced green fluorescence protein (EGFP)-fused PKC isoforms. 12-O-Tetradecanoylphorbol-13-acetate (TPA) induced neurite outgrowth and growth cone formation, effects that were blocked by GF 109203X (a PKC inhibitor), safingolTM(a PKCalpha-selective inhibitor), but not by rottlerinTM (a PKCdelta-selective inhibitor), indicating that PKCalpha may be selectively involved in neurite outgrowth and cytoskeletal changes of filamentous actin and beta-tubulin. To define the differential localization of PKC isoforms, EGFP-tagged PKCalpha, PKCgamma, and PKCdelta were transfected into GT1 neuronal cells. TPA treatment induced relocalization of PKCalpha-EGFP to growth cones and cell-cell adhesion sites, PKCgamma-EGFP to the nucleus, and PKCdelta-EGFP to the membrane ruffle, respectively. An EGFP chimera of the catalytic domain of PKCalpha (PKCalpha-Cat-EGFP), the expression of which was inducible by doxycycline, was employed to directly ascertain the effect of PKCalpha enzymatic activity on neurite outgrowth of GT1 cells. Transient transfection of PKCalpha-Cat-EGFP alone increased the neurite-outgrowth and doxycycline treatment further augmented the number of neurite-containing cells. We also examined the involvement of the extracellular signal-regulated kinase (ERK) MAP kinase in TPA-induced neurite outgrowth. TPA treatment increased phosphorylated ERK MAP kinase, but not p38 MAP kinase. Specific inhibition of PKCalpha with safingol blocked the phosphorylation of ERK induced by TPA. More importantly, both neurite outgrowth and phosphorylation of ERK by TPA were blocked by PD 098059, a specific inhibitor of MEK (MAP kinase/ERK kinase-1), but not by SB203580, a specific inhibitor of p38 MAP kinase. These results demonstrate that PKCalpha isoform-specific activation is involved in neurite outgrowth of GT1 hypothalamic neuronal cells via ERK, but not the p38 MAP kinase signal pathway.
在本研究中,我们使用几种蛋白激酶C(PKC)亚型选择性抑制剂以及基于转染的增强型绿色荧光蛋白(EGFP)融合PKC亚型的表达,研究了PKC亚型对GT1下丘脑神经元轴突生长的选择性作用。12 - 十四酰佛波醇 - 13 - 乙酸酯(TPA)诱导轴突生长和生长锥形成,这些效应被GF 109203X(一种PKC抑制剂)、safingolTM(一种PKCalpha选择性抑制剂)阻断,但未被rottlerinTM(一种PKCdelta选择性抑制剂)阻断,这表明PKCalpha可能选择性地参与轴突生长以及丝状肌动蛋白和β - 微管蛋白的细胞骨架变化。为了确定PKC亚型的差异定位,将EGFP标记的PKCalpha、PKCgamma和PKCdelta转染到GT1神经元细胞中。TPA处理分别诱导PKCalpha - EGFP重新定位到生长锥和细胞 - 细胞粘附位点,PKCgamma - EGFP重新定位到细胞核,PKCdelta - EGFP重新定位到膜皱褶。使用一种由强力霉素诱导表达的PKCalpha催化结构域的EGFP嵌合体(PKCalpha - Cat - EGFP)直接确定PKCalpha酶活性对GT1细胞轴突生长的影响。单独瞬时转染PKCalpha - Cat - EGFP增加了轴突生长,强力霉素处理进一步增加了含轴突细胞的数量。我们还研究了细胞外信号调节激酶(ERK)丝裂原活化蛋白激酶在TPA诱导的轴突生长中的作用。TPA处理增加了磷酸化的ERK丝裂原活化蛋白激酶,但未增加p38丝裂原活化蛋白激酶。用safingol特异性抑制PKCalpha可阻断TPA诱导的ERK磷酸化。更重要的是,TPA诱导的轴突生长和ERK磷酸化均被MEK(丝裂原活化蛋白激酶/ERK激酶 - 1)的特异性抑制剂PD 098059阻断,但未被p38丝裂原活化蛋白激酶的特异性抑制剂SB203580阻断。这些结果表明,PKCalpha亚型特异性激活通过ERK而非p38丝裂原活化蛋白激酶信号通路参与GT1下丘脑神经元细胞的轴突生长。